Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR – Get Free Report)’s stock price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.01 and traded as low as $0.00. Acura Pharmaceuticals shares last traded at $0.00, with a volume of 1,100 shares changing hands.
Acura Pharmaceuticals Trading Up 100.0%
About Acura Pharmaceuticals
Acura Pharmaceuticals, Inc, an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products.
Featured Articles
- Five stocks we like better than Acura Pharmaceuticals
- Retail Stocks Investing, Explained
- PayPal Stock: Why Wall Street May Be Undervaluing This Giant
- What is Put Option Volume?
- Why Vertical Aerospace Could Lead the eVTOL Market by 2028
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Is Draganfly’s Army Partnership a Game-Changer for Investors?
Receive News & Ratings for Acura Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acura Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
